September 2026
The global enzyme-linked immunosorbent assay testing market size is estimated to hit around USD 4.41 billion by 2035 increasing from USD 2.57 billion in 2026, with a CAGR of 6.18%.
September 2026
The amino acid assay kit market was valued at USD 176.75 million in 2026, with leading companies including Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories.
September 2026
The global Cystatin C assay market size is exhibited at USD 339.98 million in 2026 and is projected to hit around USD 616.35 million by 2034, with a CAGR of 7.72%.
September 2026
The global microbiology testing market size reached USD 6.88 billion in 2026 and is projected to be worth around USD 14.74 billion by 2035 with a CAGR of 8.85%.
September 2026
The global generative AI in testing market size was evaluated at USD 73.19 million in 2026 and is predicted to hit around USD 439.81 million by 2035, growing at a CAGR of 22.05%.
September 2026
The global genetic testing market size is calculated at USD 27.32 billion in 2026 and is projected to hit around USD 71.09 billion by 2035 with a soild CAGR of 11.26%.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The rapid microbiology testing market size was USD 7.37 billion in 2026, with leading rapid microbiology testing market players including Creative Diagnostics, bioMérieux, Synbiosis, Thermo Fisher Scientific,
September 2026
The global 5G testing market size is projected to surpass around USD 8.39 billion by 2034, increasing from USD 4.46 billion in 2026, with a solid CAGR of 8.22%.
September 2026
The global automation testing market size was estimated at USD 48.88 billion in 2026 and is predicted to reach around USD 169.33 billion by 2034 with a CAGR of 16.90%.
September 2026
The biological safety testing market size was evaluated at USD 6.26 billion in 2026 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
September 2026
The global multiplex assays market size was estimated at USD 2.30 billion in 2026 and is expected to hit around USD 7.51 billion by 2035, growing at a CAGR of 14.15%.
September 2026
The oxidative stress assays market size was valued at USD 1.39 billion in 2026 and is expected to hit around USD 3.33 billion by 2035, growing at a CAGR of 9.13%.
September 2026
The global non-destructive testing equipment and services market size was evaluated at USD 9.49 billion in 2026 and is predicted to surge around USD 14.76 billion by 2035, growing at a CAGR of 5.03%.
September 2026
The global lateral flow assay components market size is estimated to hit around USD 545.95 million by 2035 increasing from USD 383.58 million in 2026, with a CAGR of 4.00%.
September 2026
The global arbovirus testing market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.16 billion by 2035, growing at a CAGR of 4.80%.
September 2026
The global pharmaceutical analytical testing market size is expected to hit around USD 22.60 billion by 2035 from USD 10.76 billion in 2026 , with a CAGR of 8.62%.
September 2026
The global preterm birth and PROM testing market size is projected to hit around USD 3.45 billion by 2034 from USD 1.82 billion in 2026 with a CAGR of 8.22%.
September 2026
The global drug of abuse testing market size was estimated at USD 15.42 billion in 2026 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
September 2026
The point of care testing market size is expected to increase from USD 49.90 billion in 2026 and is projected to hit around USD 125.33 billion by 2034 with a CAGR of 12.20%.
September 2026
The direct-to-consumer laboratory testing market size is projected to hit around USD 8.69 billion by 2035 from USD 4.08 billion in 2026 with a CAGR of 8.77%.
September 2026
The global healthcare analytical testing services market size is estimated at USD 18.54 billion in 2026 and is expected to hit around USD 38.09 billion by 2035, growing a CAGR of 8.34% from 2026 to 2035.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global pharmaceutical rapid microbiology testing market size is estimated to hit around USD 6.40 billion by 2035 from USD 1.32 billion in 2025, with a CAGR of 17.10%.
September 2026
The global genetic toxicology testing market size was evaluated at USD 2.49 billion in 2026 and is predicted to hit around USD 5.97 billion by 2035, growing at a CAGR of 10.20%.
September 2026
The global EMC testing market size was evaluated at USD 3.42 billion in 2026 and is predicted to hit around USD 6.62 billion by 2035, growing at a CAGR of 7.60%.
September 2026
The global chemiluminescence immunoassay market size is projected to hit around USD 17.24 billion by 2035 from USD 9.01 billion in 2026 with a CAGR of 7.49%.
September 2026
The global pyrogen testing market size was evaluated at USD 1.89 billion in 2026 and is predicted to hit around USD 4.50 billion by 2035, growing at a CAGR of 10.10%.
September 2026
The c reactive protein testing market size stood at USD 5.59 billion in 2026, with major c reactive protein testing market companies including Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics, Siemens Healthineers AG, Abbott.
September 2026
The apoptosis assays market size stood at USD 3.19 billion in 2026, with major apoptosis assays market companies including Thermo Fisher Scientific Inc, Merck KGaA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Danaher Corporation, Promega Corporation.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com